MONDAY, April 14 (HealthDay News) — Two widely used drugs — one lowers cholesterol and one is an anti-inflammatory — may be useful in controlling prostate cancer. New research being presented at the American Association for Cancer Research annual Read More

Vioxx was removed from the market in September 2004 after it was revealed that the drug increased the risk of heart attacks and strokes. Getty Images NPR.org , November 9, 2007 · Merck & Co. said Friday that it will pay nearly $5 billion to end tens Read More

Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Feb. 9 (HealthDay News) — A new cox-2 painkiller called etoricoxib causes fewer upper gastrointestinal problems than the traditional pain medicine diclofenac, researchers report. “In the Read More

UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More

THURSDAY, Nov. 8 (HealthDay News) — Pulling the painkillers Vioxx and Bextra off the market to spare patients’ hearts may have ended up harming their stomachs, a new study suggests. Rates of gastrointestinal events serious enough to require Read More

This entry was posted on Monday, June 30th, 2008 at 12:32 pm and is filed under Bextra. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.